MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 44 filers reported holding MIRATI THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,977,000 | -43.8% | 62,813 | -47.6% | 0.01% | -37.5% |
| Q1 2015 | $3,516,000 | +90.1% | 119,912 | +20.0% | 0.01% | +100.0% |
| Q4 2014 | $1,850,000 | +5.8% | 99,912 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,749,000 | -12.5% | 99,912 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $1,998,000 | -30.1% | 99,912 | -33.4% | 0.01% | -37.5% |
| Q1 2014 | $2,859,000 | -55.6% | 149,912 | -61.3% | 0.01% | -55.6% |
| Q4 2013 | $6,441,000 | – | 387,325 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |